Exclusive: ArteraAI nabs $20M to take personalized cancer care global
ArteraAI, a developer of AI tests to personalize therapy for cancer patients, raised $20 million in additional funding, CEO A [...]
ArteraAI Secures $20 Million in Funding to Further Personalize Cancer Therapy With Multimodal AI
ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announced [...]
Prostate cancer myths and common misconceptions from an oncologist amid high-profile cases
Amid a flurry of high-profile prostate cancer announcements, doctors are weighing in to debunk common myths about the disease [...]
ArteraAI Receives Medicare Payment Rate for the ArteraAI Prostate Cancer Test
ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announced [...]
CMS payment rate established for ArteraAI prostate cancer test
The Centers for Medicare & Medicaid Services (CMS) have established a payment rate for the ArteraAI prostate cancer test, [...]
Startups Are Using AI to Predict Responses to Cancer Drugs
Biomedical startups are using artificial intelligence to predict the response patients will have to cancer treatments, aiming [...]
AI is helping the healthcare industry and could transform the way patients get drugs and treatments
From staff shortages and a growing population to decreased budgets and increased admin work, doctors and other medical provid [...]
Artificial intelligence experts share 6 of the biggest AI innovations of 2023: ‘A landmark year’
From cancer care to communications, here’s where AI moved the needle in healthcare. If you received medical care any time thi [...]
AI Models in Prostate Cancer Tackle Treatment Disparities Facing African American Men
In an interview with Peers & Perspectives in Oncology, Rana McKay, MD, explains how an AI model can affect the disparitie [...]